ArticleLipids in health and disease2024

Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.